https://www.profitablecpmrate.com/nsirjwzb79?key=c706907e420c1171a8852e02ab2e6ea4
Skip to content 
This report is from this week’s CNBC’s UK Exchange newsletter. Like what you see? You can subscribe here. The dispatch There is an old British saying about buses: you wait ages for one and then two arrive at once. Pharmaceuticals analysts experienced something similar on Monday as the big two U.K. drugmakers — GSK and AstraZeneca — … Read more
Stocks listed in Europe were higher on Monday, as investors monitored the impact of a potential U.S. government shutdown later in the week. The pan-European Stoxx 600 was up about 0.14% by 3:25 p.m. in London (10:25 a.m. Eastern time), with most sectors in positive territory. The FTSE 100 traded 0.17% higher, although the DAX … Read more
A view of the AstraZeneca office in Mölndal, Sweden, on September 12, 2024. Nurphoto | Getty Images AstraZeneca CEO Pascal Soriot on Tuesday reiterated the pharmaceutical firm’s commitment to the U.S. market amid reports that he is considering shifting its listing stateside. Soriot said the U.K.-listed company had many reasons to be in the U.S., … Read more
British pharmaceutical giant AstraZeneca said Tuesday it would invest $50 billion in the United States amid a looming deadline of ramped-up tariffs from Washington. A large chunk of the funds will go toward building a multi-billion-dollar manufacturing centre in Virginia, the company said in a statement, adding that it expects 50 percent of its revenue … Read more
The office building of international biopharmaceutical company AstraZeneca. Cfoto | Future Publishing | Getty Images AstraZeneca on Monday said it plans to invest $50 billion in bolstering its U.S. manufacturing and research capabilities by 2030, becoming the latest pharmaceutical firm to ramp up its stateside spending in the wake of U.S. trade tariffs. The Anglo-Swedish … Read more
AstraZeneca CEO Pascal Soriot, pictured in London on June 28, 2023, reportedly wants to move the company’s stock listing from London to the United States. Justin Tallis | Afp | Getty Images Pressure is piling on London’s stock exchange, with reports that British pharma giant AstraZeneca may move its listing to the U.S. delivering yet … Read more
The Food and Drug Administration on Monday approved Merck’s shot designed to protect infants from respiratory syncytial virus during their first season of the virus, bringing to market a rival to a similar treatment from Sanofi and AstraZeneca. The decision will allow the company to launch the drug, which will be marketed as Enflonsia, ahead … Read more
British pharmaceutical giant AstraZeneca on Tuesday vowed to keep investing and growing its business in the United States, ahead of President Donald Trump’s possible tariffs on the sector. “Our company is firmly committed to investing and growing in the US,” chief executive Pascal Soriot said in an earnings statement, which also announced that first quarter … Read more
Outside the Macclesfield factory of AstraZeneca. Christopher Furlong | Getty Images News | Getty Images British pharmaceutical giant AstraZeneca on Friday said that it will invest $2.5 billion in a research and development center in Chinese capital Beijing. The new hub is expected to take AstraZeneca’s Beijing workforce to around 1,700 employees. The investment in Beijing … Read more
Profit after tax rose to $7 billion last year, up from $6 billion in 2023, the company said, noting a sharp increase in sales of cancer medicines. Read More
https://www.profitablecpmrate.com/nsirjwzb79?key=c706907e420c1171a8852e02ab2e6ea4